Document Type
Blog Post
Publication Date
9-20-2022
Digital USD Citation
Serbin, Kenneth P. PhD, "Roche confirms second, more focused, trial of Huntington’s disease drug will start early next year" (2022). At Risk for Huntington's Disease. 333.
https://digital.sandiego.edu/huntingtons/333
COinS